pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant
Open Access
- 29 May 2012
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 107 (1), 84-90
- https://doi.org/10.1038/bjc.2012.198
Abstract
Background: Methods: Results: Conclusion:This publication has 35 references indexed in Scilit:
- Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical studyDiagnostic Pathology, 2011
- Survivin and IAP proteins in cell-death mechanismsBiochemical Journal, 2010
- Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX-2): prognostic value and survival of endometrial cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 2009
- Endometrial Eosinophilic Syncytial Change Related to Breakdown: Immunohistochemical Evidence Suggests a Regressive ProcessInternational Journal of Gynecological Pathology, 2008
- COX-2 and survivin are overexpressed and positively correlated in endometrial carcinomaGynecologic Oncology, 2007
- Carcinoma of the Corpus UteriInternational Journal of Gynecology & Obstetrics, 2006
- Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometriumInternational Journal of Gynecologic Cancer, 2006
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958